Skip to content
Home
About us
Co-founders
Our Team
Our Product Pipeline
Our Technology
Scientific Advisors
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Home
About us
Co-founders
Our Team
Our Product Pipeline
Our Technology
Scientific Advisors
Investors
Science
AMD and Eyecyte-RPE
TM
Retinitis pigmentosa and Eyecyte-PRP
TM
AAV – mediated gene therapy
Publications
Resources
News and Media
Recognition
Collaborations
Research Alliance
Careers
Contact Us
Collaboration agreement for safety and efficacy studies using iPSC-derived Dopaminergic neuronal progenitors in rodent models of Parkinson’s Disease
Home
Collaboration
Collaboration agreement for safety and efficacy studies using iPSC-derived Dopaminergic neuronal progenitors in rodent models of Parkinson’s Disease
Post Author:
eyetem@admin
Post navigation
Next Post
Collaboration on modelling of inherited retinal disorders with complex mutations and developing a high-throughput drug screening platform
